Simulations Plus (SLP) 6.30 $SLP
Simulations Plus, Inc. Passes Its Checkup
Sergio Heiber - at Seeking Alpha - Thu Jan 29, 9:34AM CST
SLP: 6.30 (+0.04)
Exa Corp., Growth Will Drive Past Expectations
The Bulldog Investor - at Seeking Alpha - Mon Jan 26, 5:52PM CST
Business Description: Exa Corporation (NASDAQ: EXA ) competes in the digital simulation space, where it is a leader within fluid simulation, working with ground transportation customers (96% of 2014 sales). Engineers use EXA's software to simulate,...
SLP: 6.30 (+0.04), ANSS: 86.26 (+0.36), EXA: 10.46 (+0.09)
Simulations Plus' (SLP) CEO Walter Woltosz on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 15, 8:17AM CST
SLP: 6.30 (+0.04)
Simulations Plus declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 7:46AM CST
SLP: 6.30 (+0.04)
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Business Wire - Thu Jan 15, 7:01AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Monday, February 2, 2015, for shareholders of record as of Monday, January 26, 2015.
SLP: 6.30 (+0.04)
Simulations Plus beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:19PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports First Quarter FY2015 Financial Results
Business Wire - Mon Jan 12, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.30 (+0.04)
Simulations Plus reports January 14
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 8:35AM CST
SLP: 6.30 (+0.04)
Simulations Plus Sets Date for 1st Quarter 2015 Earnings Release and Conference Call
Business Wire - Fri Jan 09, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2015 fiscal year, ended November 30, 2014, with the U.S. Securities and Exchange Commission on Wednesday, January 14, 2015. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on January 14, 2015, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.30 (+0.04)
Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015
Business Wire - Mon Dec 22, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Dr. Ted Grasela, President, will present at the Sidoti & Company, LLC, Emerging Growth Institutional Investor Forum on January 12, 2015. The conference will be held at the Grand Hyatt Hotel in Manhattan. The Company's group presentation is scheduled for 9:20 a.m. on the 12th in Estate 5 and management will be available throughout that day for one-on-one meetings. Please contact Sidoti & Company or email slp@haydenir.com to schedule a meeting.
SLP: 6.30 (+0.04)
Simulations Plus Q1 revenues up 50%
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 3:34PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Business Wire - Wed Dec 03, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.30 (+0.04)
Simulations Plus (SLP) CEO Walt Woltosz on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 25, 10:04PM CST
SLP: 6.30 (+0.04)
Simulations Plus posts 4Q profit
Automated Insights - Tue Nov 25, 4:16PM CST
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Tuesday reported net income of $223,000, or 1 cent per share, in its fiscal fourth quarter.
SLP: 6.30 (+0.04)
Simulations Plus EPS of $0.01
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:29PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Business Wire - Tue Nov 25, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2014 fiscal year (FY14) and fourth quarter (4Q14) ended August 31, 2014.
SLP: 6.30 (+0.04)
Simulations Plus to Attend The Benchmark Company, LLC's Micro Cap Discovery Conference in Chicago on December 11
Business Wire - Mon Nov 24, 7:45AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, and Ted Grasela, President, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, Dec. 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe St., Chicago, IL, from 8 a.m. to 2:30 p.m. Please email slp@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
SLP: 6.30 (+0.04)
Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3
Business Wire - Mon Nov 24, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, will present at the LD MICRO Conference on Wednesday, December 3, 2014, at 2:30 p.m. PST in Track 1. The conference will be held Dec. 2-4, 2014, at the Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, California. The Company's presentation will be available for the public to access via its corporate website, www.simulations-plus.com or at http://wsw.com/webcast/ldmicro7/slp. This webcast will be archived for 90 days following the live presentation. Simulations Plus management will be available during the day on Dec. 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
SLP: 6.30 (+0.04)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Business Wire - Tue Nov 18, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K for the 2014 fiscal year ended August 31, 2014, with the U.S. Securities and Exchange Commission by Monday, December 1, 2014. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on Tuesday, November 25, 2014, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.30 (+0.04)
Simulations Plus Announces Changes in Board of Directors
Business Wire - Wed Nov 05, 7:02AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that a member of its Board of Directors has elected to retire from the board and a new, outside member has been elected to fill the vacancy.
SLP: 6.30 (+0.04)
Simulations Plus, Inc. Passes Its Checkup
Sergio Heiber - at Seeking Alpha - Thu Jan 29, 9:34AM CST
SLP: 6.30 (+0.04)
Exa Corp., Growth Will Drive Past Expectations
The Bulldog Investor - at Seeking Alpha - Mon Jan 26, 5:52PM CST
Business Description: Exa Corporation (NASDAQ: EXA ) competes in the digital simulation space, where it is a leader within fluid simulation, working with ground transportation customers (96% of 2014 sales). Engineers use EXA's software to simulate,...
SLP: 6.30 (+0.04), ANSS: 86.26 (+0.36), EXA: 10.46 (+0.09)
Simulations Plus' (SLP) CEO Walter Woltosz on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 15, 8:17AM CST
SLP: 6.30 (+0.04)
Simulations Plus declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 15, 7:46AM CST
SLP: 6.30 (+0.04)
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Business Wire - Thu Jan 15, 7:01AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly cash dividend of $0.05 per share to its shareholders. This cash dividend will be distributed on Monday, February 2, 2015, for shareholders of record as of Monday, January 26, 2015.
SLP: 6.30 (+0.04)
Simulations Plus beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 1:19PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports First Quarter FY2015 Financial Results
Business Wire - Mon Jan 12, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.30 (+0.04)
Simulations Plus reports January 14
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 8:35AM CST
SLP: 6.30 (+0.04)
Simulations Plus Sets Date for 1st Quarter 2015 Earnings Release and Conference Call
Business Wire - Fri Jan 09, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2015 fiscal year, ended November 30, 2014, with the U.S. Securities and Exchange Commission on Wednesday, January 14, 2015. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on January 14, 2015, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.30 (+0.04)
Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015
Business Wire - Mon Dec 22, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Dr. Ted Grasela, President, will present at the Sidoti & Company, LLC, Emerging Growth Institutional Investor Forum on January 12, 2015. The conference will be held at the Grand Hyatt Hotel in Manhattan. The Company's group presentation is scheduled for 9:20 a.m. on the 12th in Estate 5 and management will be available throughout that day for one-on-one meetings. Please contact Sidoti & Company or email slp@haydenir.com to schedule a meeting.
SLP: 6.30 (+0.04)
Simulations Plus Q1 revenues up 50%
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 3:34PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Business Wire - Wed Dec 03, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported preliminary revenues for its first quarter of fiscal year 2015 ended November 30, 2014 (1QFY15).
SLP: 6.30 (+0.04)
Simulations Plus (SLP) CEO Walt Woltosz on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 25, 10:04PM CST
SLP: 6.30 (+0.04)
Simulations Plus posts 4Q profit
Automated Insights - Tue Nov 25, 4:16PM CST
LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Tuesday reported net income of $223,000, or 1 cent per share, in its fiscal fourth quarter.
SLP: 6.30 (+0.04)
Simulations Plus EPS of $0.01
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:29PM CST
SLP: 6.30 (+0.04)
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Business Wire - Tue Nov 25, 3:01PM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2014 fiscal year (FY14) and fourth quarter (4Q14) ended August 31, 2014.
SLP: 6.30 (+0.04)
Simulations Plus to Attend The Benchmark Company, LLC's Micro Cap Discovery Conference in Chicago on December 11
Business Wire - Mon Nov 24, 7:45AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, and Ted Grasela, President, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, Dec. 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe St., Chicago, IL, from 8 a.m. to 2:30 p.m. Please email slp@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
SLP: 6.30 (+0.04)
Simulations Plus to Present at the LD MICRO Conference in Los Angeles on December 3
Business Wire - Mon Nov 24, 7:30AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, will present at the LD MICRO Conference on Wednesday, December 3, 2014, at 2:30 p.m. PST in Track 1. The conference will be held Dec. 2-4, 2014, at the Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd., Los Angeles, California. The Company's presentation will be available for the public to access via its corporate website, www.simulations-plus.com or at http://wsw.com/webcast/ldmicro7/slp. This webcast will be archived for 90 days following the live presentation. Simulations Plus management will be available during the day on Dec. 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
SLP: 6.30 (+0.04)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Business Wire - Tue Nov 18, 7:30AM CST
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form 10-K for the 2014 fiscal year ended August 31, 2014, with the U.S. Securities and Exchange Commission by Monday, December 1, 2014. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company's performance on Tuesday, November 25, 2014, at 1:15 p.m. PST / 4:15 p.m. EST.
SLP: 6.30 (+0.04)
Simulations Plus Announces Changes in Board of Directors
Business Wire - Wed Nov 05, 7:02AM CST
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that a member of its Board of Directors has elected to retire from the board and a new, outside member has been elected to fill the vacancy.
SLP: 6.30 (+0.04)
